4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-18-014752
Options or other derivatives
- President & CEO acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| OAKES FRANK R. President & CEO | 2018-03-12 | Grant or award · Share Option (Right to Buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/tv488520_4.xml…